Epithelial retinal tears
Retinal epithelial tears may prove to be yet another indication for the use of intravitreal anti-VEGF agents, according to the results of a retrospective casecontrol study. The two-centre study involved nine patients with epithelial retinal tears who received no treatment and 12 patients who received treatment with a mean of 5.75 intravitreal injections of 0.3mg/0.09ml pegaptanib, 1.25mg/0.05ml bevacizumab, or 0.5mg/0.05ml ranibizumab, depending on the time of the intervention and centre where the patients received their therapy. From the third month to the final followup visit, the study’s investigators found a statistically significant difference between the mean visual acuities of the two groups (p = 0.034).
(Coco et al Ophthalmologica 2012; DOI: 10.1159/000338730)
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.